Dr. Behnood Bikdeli and Dr. C. Michael Gibson Discuss: Atorvastatin Versus Placebo In Critically-ill Patients With Covid-19: The Inspiration-S Double Blind Randomized Controlled Trial May 15, 2021 Disclosures: TBD
Dr. Mikhail Kosiborod and Dr. C. Michael Gibson Discuss: Effects Of Dapagliflozin On Prevention Of Major Clinical Events And Recovery In Patients With Respiratory Failure Due To COVID-19 – Main Results From The DARE-19 Randomized Trial May 15, 2021 Disclosures: TBD
Dr. John Teerlink and Dr. C. Michael Gibson Discuss: Impact Of Ejection Fraction On The Therapeutic Effect Of Omecamtiv Mecarbil In Patients With Heart Failure And Reduced Ejection Fraction: A Secondary Analysis From GALACTIC-HF May 15, 2021 Disclosures: TBD
Dr. Douglas Mann and Dr. C. Michael Gibson Discuss: Sacubitril/Valsartan (LCZ696) In Patients With Advanced Heart Failure And Reduced Ejection Fraction: Results Of The LIFE Trial May 15, 2021 Disclosures: TBD
Dr. Rupert Bauersachs and Dr. C. Michael Gibson Discuss: Reductions In Total Ischemic Events With Rivaroxaban In Patients With Symptomatic Pad After Revascularization: The VOYAGER PAD Trial May 15, 2021 Disclosures: TBD
Dr. Pierre Amarenco Presents: Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Tia of Atherosclerotic Origin February 10, 2021 Disclosures: TBA
Dr. Alexandra J Lansky Presents: A Prospective Multicenter Randomized Controlled Trial Assessing the Safety and Efficacy of the BuMA Supreme™ Biodegradable Drug Coated Coronary Stent System in Patients With Stable or Non-ST Elevation Acute Coronary Syndromes: Primary Endpoint Results of the PIONEER III Trial February 10, 2021 Disclosures: TBA
Dr. Otavio Berwanger and Dr. C. Michael Gibson Discuss: Rivaroxaban Versus Warfarin In Patients With Bioprosthetic Mitral Valves And Atrial Fibrillation Or Flutter: Primary Results From The RIVER Randomized Trial November 14, 2020 Disclosures: TBA
Dr. Robert Byrne and Dr. C. Michael Gibson Discuss: COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients October 17, 2020 Disclosures: TBD
Dr. Damien Collison and Dr. C. Michael Gibson Discuss: TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization October 16, 2020 Disclosures: TBD